Home  >  Products  >  KLK3 (kallikrein-related peptidase 3 ) Blocking Peptide (the middle region of KLK3)(100ug)
KLK3 (kallikrein-related peptidase 3 ) Blocking Peptide (the middle region of KLK3)(100ug)

KLK3 (kallikrein-related peptidase 3 ) Blocking Peptide (the middle region of KLK3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KLK3 Antibody (ARP41879_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP41879
Size: 100ug
Weight: 26kDa
Gene: 354
Format: Lyophilized powder
Target: Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its protein product is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. Serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms.
Alternative names: APS; KLK2A1; PSA; hK3
See Full Product Listings >